[go: up one dir, main page]

NO20042476L - Anvendelse av desoxypeganin for behandling av klinisk depresjon - Google Patents

Anvendelse av desoxypeganin for behandling av klinisk depresjon

Info

Publication number
NO20042476L
NO20042476L NO20042476A NO20042476A NO20042476L NO 20042476 L NO20042476 L NO 20042476L NO 20042476 A NO20042476 A NO 20042476A NO 20042476 A NO20042476 A NO 20042476A NO 20042476 L NO20042476 L NO 20042476L
Authority
NO
Norway
Prior art keywords
desoxypeganine
treatment
clinical depression
depression
clinical
Prior art date
Application number
NO20042476A
Other languages
English (en)
Other versions
NO326446B1 (no
Inventor
Joachim Moormann
Hermann Mucke
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20042476L publication Critical patent/NO20042476L/no
Publication of NO326446B1 publication Critical patent/NO326446B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO20042476A 2001-12-21 2004-06-14 Anvendelse av deoksypeganin, som fri base eller som et syreaddisjonssalt, for fremstilling av et medikament til behandling av klinisk depresjon NO326446B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10163667A DE10163667B4 (de) 2001-12-21 2001-12-21 Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
PCT/EP2002/014274 WO2003053445A1 (de) 2001-12-21 2002-12-14 Verwendung von desoxypeganin zur behandlung der klinischen depression

Publications (2)

Publication Number Publication Date
NO20042476L true NO20042476L (no) 2004-06-14
NO326446B1 NO326446B1 (no) 2008-12-08

Family

ID=7710660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042476A NO326446B1 (no) 2001-12-21 2004-06-14 Anvendelse av deoksypeganin, som fri base eller som et syreaddisjonssalt, for fremstilling av et medikament til behandling av klinisk depresjon

Country Status (29)

Country Link
US (1) US20050009813A1 (no)
EP (1) EP1461042B1 (no)
JP (1) JP2005513105A (no)
KR (1) KR100614504B1 (no)
CN (1) CN1283253C (no)
AR (1) AR037967A1 (no)
AT (1) ATE404203T1 (no)
AU (1) AU2002363874B2 (no)
BR (1) BR0215306A (no)
CA (1) CA2471338C (no)
CZ (1) CZ301210B6 (no)
DE (2) DE10163667B4 (no)
DK (1) DK1461042T3 (no)
EA (1) EA006896B1 (no)
ES (1) ES2312657T3 (no)
HU (1) HUP0402298A3 (no)
IL (2) IL162509A0 (no)
MX (1) MXPA04006125A (no)
MY (1) MY138088A (no)
NO (1) NO326446B1 (no)
NZ (1) NZ533249A (no)
PL (1) PL370315A1 (no)
PT (1) PT1461042E (no)
SI (1) SI1461042T1 (no)
SK (1) SK287152B6 (no)
TW (1) TWI241189B (no)
UA (1) UA76254C2 (no)
WO (1) WO2003053445A1 (no)
ZA (1) ZA200404053B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
ES2708551T3 (es) * 2002-12-20 2019-04-10 Niconovum Ab Material particulado que contiene nicotina con una celulosa cristalina
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
FR2865650B1 (fr) * 2004-01-30 2008-06-13 Biocortech Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
CN101433565B (zh) * 2008-11-26 2013-06-05 上海中医药大学 骆驼蓬属种子总生物碱提取物和它们的制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Also Published As

Publication number Publication date
DE10163667A1 (de) 2003-07-10
ZA200404053B (en) 2004-10-12
BR0215306A (pt) 2004-12-21
AU2002363874A1 (en) 2003-07-09
HK1066742A1 (zh) 2005-04-01
HUP0402298A3 (en) 2011-03-28
CZ301210B6 (cs) 2009-12-09
ATE404203T1 (de) 2008-08-15
DE50212649D1 (de) 2008-09-25
US20050009813A1 (en) 2005-01-13
CA2471338A1 (en) 2003-07-03
CN1283253C (zh) 2006-11-08
CZ2004739A3 (cs) 2004-12-15
SK2582004A3 (en) 2004-12-01
EP1461042A1 (de) 2004-09-29
DE10163667B4 (de) 2006-10-26
ES2312657T3 (es) 2009-03-01
AU2002363874B2 (en) 2007-12-13
CN1604781A (zh) 2005-04-06
EA200400751A1 (ru) 2004-12-30
SI1461042T1 (sl) 2009-02-28
NZ533249A (en) 2007-05-31
PT1461042E (pt) 2008-11-03
DK1461042T3 (da) 2008-12-01
NO326446B1 (no) 2008-12-08
TW200301124A (en) 2003-07-01
EP1461042B1 (de) 2008-08-13
UA76254C2 (en) 2006-07-17
MXPA04006125A (es) 2005-05-16
KR100614504B1 (ko) 2006-08-22
MY138088A (en) 2009-04-30
WO2003053445A1 (de) 2003-07-03
WO2003053445A8 (de) 2004-07-01
SK287152B6 (sk) 2010-01-07
JP2005513105A (ja) 2005-05-12
HUP0402298A2 (hu) 2005-02-28
TWI241189B (en) 2005-10-11
IL162509A0 (en) 2005-11-20
PL370315A1 (en) 2005-05-16
KR20040068327A (ko) 2004-07-30
AR037967A1 (es) 2004-12-22
EA006896B1 (ru) 2006-04-28
IL162509A (en) 2010-06-16
CA2471338C (en) 2009-02-24

Similar Documents

Publication Publication Date Title
DE60237823D1 (de) Medizinisches behandlungsinstrument
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20035522D0 (no) Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20045554L (no) Fremgangsmate for behandling av diabetes
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20041968L (no) Anvendelse av cystationin
NO20033804L (no) Karbamatforbindelser for behandling av smerte
DE50200930D1 (de) Medizinisches greifinstrument
DE60326190D1 (de) des Körpers
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
NO20033290L (no) Pyrrolderivater for behandling av cytokinformidlede sykdommer
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom
NO20034972L (no) Behandling av ADHD
NO20025765D0 (no) Kombinasjonssett for behandling av malaria
NO20042542L (no) Anvendelse av ascomycin for behandling av blefarit
NO20033160D0 (no) Anordning for behandling av gravann

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees